BioCentury
ARTICLE | Clinical News

Bone resorption assay regulatory update

December 20, 1999 8:00 AM UTC

Massachusetts General Hospital received U.S. Patent No. 5,972,623 covering a helical peptide that is a degradation fragment of Type I collagen, and an immunoassay method for measuring the peptide. QD...